Quantification of phosphorylated metabolites based on <sup>31</sup>P spectra for different tissue samples and experimental groups.
<p>Values displayed as metabolite peak areas normalized to sample weight (average ±SD) for brain (<b>A</b>) and heart (<b>B</b>) samples of CTR, GLC and ACE groups. PC could not be quantified properly in heart samples due to overlap with 2,3-diphosphoglycerate (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0208784#pone.0208784.g005" target="_blank">Fig 5</a>). Significant differences between AGA and FGR subjects are indicated (* p<0.05, two-tailed unpaired t-Test).</p
Biochemistry, Medicine, Cell Biology, Molecular Biology, Physiology, Developmental Biology, Cancer, Computational Biology, AGA, Lac C 2C, 13 C-labelled substrate infusions, term FGR fetuses, gestation, 2 D spectra, cell membrane turnover, rabbit model, growth restriction, New Zealand rabbits, heart apex regions, metabolism, vivo multinuclear HRMAS Background, phospholipid breakdown products, non-infused control hearts, multinuclear 1 D
DOI identifier: 10.1371/journal.pone.0208784.g006
Sorry, we are unable to provide the full text but you may find it at the